Late-stage biotech developing antibiotics for multi-drug resistant bacteria.
Industry: Health Care
First Day Return: -19.9%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 07/13/2016 |
Offer Price | $6.98 |
Price Range $8.38 - $8.38 | |
Offer Shares (mm) | 3.6 |
Deal Size ($mm) | $25 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 11/17/2016 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $25 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | New York, NY, United States |
Founded | 2003 |
Employees at IPO | 4 |
Website www.motifbio.com |